Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Prothena Corp (NQ: PRTA ) 16.41 -0.70 (-4.09%) Streaming Delayed Price Updated: 12:48 PM EDT, Oct 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Prothena Corp < Previous 1 2 3 4 5 6 7 Next > How Is The Market Feeling About Prothena Corp? September 28, 2022 Prothena Corp's (NASDAQ:PRTA) short percent of float has fallen 8.23% since its last report. The company recently reported that it has 2.46 million shares sold short, which is 13.83% of all regular... Via Benzinga US Stocks Mixed; Wholesale Inventories Increase 1.3% In August September 28, 2022 U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022 September 28, 2022 Upgrades Via Benzinga What's Going On With Prothena Stock Up Over 60% Today September 28, 2022 Prothena Corporation PLC (NASDAQ: PRTA) shares are trading higher by 61.27% to $49.88 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co. Via Benzinga Recap: Prothena Corp Q2 Earnings August 08, 2022 Prothena Corp (NASDAQ:PRTA) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Via Benzinga Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs March 16, 2022 Prothena Corporation plc (NASDAQ: PRTA) Via Benzinga Recap: Prothena Corp Q4 Earnings February 17, 2022 Prothena Corp (NASDAQ:PRTA) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session September 28, 2022 Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday September 28, 2022 It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning. Via InvestorPlace Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket September 28, 2022 Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday. Via Benzinga Earnings Scheduled For February 17, 2022 February 17, 2022 Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. Via Benzinga Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session September 28, 2022 U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today’s pre-market trading session. Via Benzinga Prothena Corp's Return On Capital Employed Overview August 31, 2022 Prothena Corp (NASDAQ:PRTA) brought in sales totaling $1.31 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 13.65%, resulting in a loss of $41.24 million. Via Benzinga Jim Cramer Says This Company Is A Great One June 16, 2022 On CNBC’s "Mad Money Lightning Round," Jim Cramer said Woodside Energy Group Ltd (NYSE: WDS) is a great company, with a great yield. Via Benzinga The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study May 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Scheduled For August 8, 2022 August 08, 2022 Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter. Via Benzinga A Preview Of Prothena Corp's Earnings May 04, 2022 Prothena Corp (NASDAQ:PRTA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Prothena Corp... Via Benzinga Why RBC Capital Sees 'Multiple High-Risk' On This Neurology-Focused Stock May 02, 2022 RBC Capital Markets writes that Prothena Corporation plc (NASDAQ: PRTA) believes that the recent stock downside provides an entry point and that progress with the programs and improved sentiment in the... Via Benzinga 10 Biggest Price Target Changes For Monday May 02, 2022 Morgan Stanley boosted Archer-Daniels-Midland Company (NYSE: ADM) price target from $69 to $94. Archer-Daniels-Midland shares fell 0.5% to $89.10 in pre-market trading. Via Benzinga Prothena Receives FDA Fast Track Designation for PRX012 for the Treatment of Alzheimer's Disease April 26, 2022 Prothena Corporation plc (NASDAQ: PRTA) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-amyloid beta (Aβ) antibody therapy drug candidate... Via Benzinga The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings February 18, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Agios's Metabolic Disorder Treatment Receives FDA Approval (NASDAQ: AGIO... Via Benzinga The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios February 17, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... Via Benzinga The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More February 13, 2022 Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... Via Benzinga Why Jim Cramer Prefers This Mining Stock Over Vale January 13, 2022 On CNBC’s "Mad Money Lightning Round," Jim Cramer said ChargePoint Holdings, Inc. (NYSE: Via Benzinga The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact January 13, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Says Lead Monoclonal Antibody Effective Against Omicron Variant Adagio... Via Benzinga 4 Stocks Insiders Are Buying January 13, 2022 When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session January 12, 2022 Gainers Biomerica (NASDAQ:BMRA) stock inc... Via Benzinga 50 Biggest Movers From Yesterday January 13, 2022 Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for... Via Benzinga 28 Stocks Moving In Wednesday's Mid-Day Session January 12, 2022 Gainers Immuron Limited (NASDAQ: IMRN) shares jumped 40.2% to $3.5887. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing... Via Benzinga Mid-Morning Market Update: Markets Open Higher; US Inflation Rate Rises To 7% In December January 12, 2022 Following the market opening Wednesday, the Dow traded up 0.56% to 36,453.49 while the NASDAQ rose 0.79% to 15,273.08. The S&P also rose, gaining, 0.60% to 4,741.45. The U.S.... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.